These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 14672353)
1. Role of gastrointestinal hormones in postprandial reduction of bone resorption. Henriksen DB; Alexandersen P; Bjarnason NH; Vilsbøll T; Hartmann B; Henriksen EE; Byrjalsen I; Krarup T; Holst JJ; Christiansen C J Bone Miner Res; 2003 Dec; 18(12):2180-9. PubMed ID: 14672353 [TBL] [Abstract][Full Text] [Related]
2. Disassociation of bone resorption and formation by GLP-2: a 14-day study in healthy postmenopausal women. Henriksen DB; Alexandersen P; Hartmann B; Adrian CL; Byrjalsen I; Bone HG; Holst JJ; Christiansen C Bone; 2007 Mar; 40(3):723-9. PubMed ID: 17081815 [TBL] [Abstract][Full Text] [Related]
3. Bone resorption is decreased postprandially by intestinal factors and glucagon-like peptide-2 is a possible candidate. Holst JJ; Hartmann B; Gottschalck IB; Jeppesen PB; Miholic J; Henriksen DB Scand J Gastroenterol; 2007 Jul; 42(7):814-20. PubMed ID: 17558904 [TBL] [Abstract][Full Text] [Related]
4. Four-month treatment with GLP-2 significantly increases hip BMD: a randomized, placebo-controlled, dose-ranging study in postmenopausal women with low BMD. Henriksen DB; Alexandersen P; Hartmann B; Adrian CL; Byrjalsen I; Bone HG; Holst JJ; Christiansen C Bone; 2009 Nov; 45(5):833-42. PubMed ID: 19631303 [TBL] [Abstract][Full Text] [Related]
5. Effects of treatment with glucagon-like peptide-2 on bone resorption in colectomized patients with distal ileostomy or jejunostomy and short-bowel syndrome. Gottschalck IB; Jeppesen PB; Hartmann B; Holst JJ; Henriksen DB Scand J Gastroenterol; 2008; 43(11):1304-10. PubMed ID: 18609184 [TBL] [Abstract][Full Text] [Related]
6. Differential effects of subcutaneous GLP-1 on gastric emptying, antroduodenal motility, and pancreatic function in men. Schirra J; Kuwert P; Wank U; Leicht P; Arnold R; Göke B; Katschinski M Proc Assoc Am Physicians; 1997 Jan; 109(1):84-97. PubMed ID: 9010920 [TBL] [Abstract][Full Text] [Related]
7. Prolonged and enhanced secretion of glucagon-like peptide 1 (7-36 amide) after oral sucrose due to alpha-glucosidase inhibition (acarbose) in Type 2 diabetic patients. Seifarth C; Bergmann J; Holst JJ; Ritzel R; Schmiegel W; Nauck MA Diabet Med; 1998 Jun; 15(6):485-91. PubMed ID: 9632123 [TBL] [Abstract][Full Text] [Related]
8. Associations between Postprandial Gut Hormones and Markers of Bone Remodeling. Jensen NW; Clemmensen KKB; Jensen MM; Pedersen H; Færch K; Diaz LJ; Quist JS; Størling J Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579074 [TBL] [Abstract][Full Text] [Related]
9. Incretin and islet hormonal responses to fat and protein ingestion in healthy men. Carr RD; Larsen MO; Winzell MS; Jelic K; Lindgren O; Deacon CF; Ahrén B Am J Physiol Endocrinol Metab; 2008 Oct; 295(4):E779-84. PubMed ID: 18612044 [TBL] [Abstract][Full Text] [Related]
10. Reduction of hepatic insulin clearance after oral glucose ingestion is not mediated by glucagon-like peptide 1 or gastric inhibitory polypeptide in humans. Meier JJ; Holst JJ; Schmidt WE; Nauck MA Am J Physiol Endocrinol Metab; 2007 Sep; 293(3):E849-56. PubMed ID: 17609256 [TBL] [Abstract][Full Text] [Related]
11. Subcutaneous GIP and GLP-2 inhibit nightly bone resorption in postmenopausal women: A preliminary study. Skov-Jeppesen K; Veedfald S; Madsbad S; Holst JJ; Rosenkilde MM; Hartmann B Bone; 2021 Nov; 152():116065. PubMed ID: 34153529 [TBL] [Abstract][Full Text] [Related]
13. Glucagon-like peptide-1 secretion is influenced by perfusate glucose concentration and by a feedback mechanism involving somatostatin in isolated perfused porcine ileum. Hansen L; Hartmann B; Mineo H; Holst JJ Regul Pept; 2004 Apr; 118(1-2):11-8. PubMed ID: 14759551 [TBL] [Abstract][Full Text] [Related]
14. What do we know about the secretion and degradation of incretin hormones? Deacon CF Regul Pept; 2005 Jun; 128(2):117-24. PubMed ID: 15780431 [TBL] [Abstract][Full Text] [Related]
15. Effects of the dipeptidyl peptidase-IV inhibitor vildagliptin on incretin hormones, islet function, and postprandial glycemia in subjects with impaired glucose tolerance. Rosenstock J; Foley JE; Rendell M; Landin-Olsson M; Holst JJ; Deacon CF; Rochotte E; Baron MA Diabetes Care; 2008 Jan; 31(1):30-5. PubMed ID: 17947341 [TBL] [Abstract][Full Text] [Related]
16. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women. Papakitsou EF; Margioris AN; Dretakis KE; Trovas G; Zoras U; Lyritis G; Dretakis EK; Stergiopoulos K Maturitas; 2004 Mar; 47(3):185-93. PubMed ID: 15036488 [TBL] [Abstract][Full Text] [Related]
17. Lower glucose-dependent insulinotropic polypeptide (GIP) response but similar glucagon-like peptide 1 (GLP-1), glycaemic, and insulinaemic response to ancient wheat compared to modern wheat depends on processing. Bakhøj S; Flint A; Holst JJ; Tetens I Eur J Clin Nutr; 2003 Oct; 57(10):1254-61. PubMed ID: 14506486 [TBL] [Abstract][Full Text] [Related]
18. Long-term variability of markers of bone turnover in postmenopausal women and implications for their clinical use: the OFELY study. Garnero P; Mulleman D; Munoz F; Sornay-Rendu E; Delmas PD J Bone Miner Res; 2003 Oct; 18(10):1789-94. PubMed ID: 14584889 [TBL] [Abstract][Full Text] [Related]
19. High serum IGFBP-2 is predictive of increased bone turnover in aging men and women. Amin S; Riggs BL; Melton LJ; Achenbach SJ; Atkinson EJ; Khosla S J Bone Miner Res; 2007 Jun; 22(6):799-807. PubMed ID: 17352648 [TBL] [Abstract][Full Text] [Related]